Not available
Quote | CytomX Therapeutics Inc. (NASDAQ:CTMX)
Last: | $1.50 |
---|---|
Change Percent: | -2.11% |
Open: | $1.45 |
Close: | $1.50 |
High: | $1.51 |
Low: | $1.4305 |
Volume: | 572,091 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | CytomX Therapeutics Inc. (NASDAQ:CTMX)
2024-07-15 15:37:04 ET Summary CytomX Therapeutics develops innovative oncology treatments using its Probody platform, creating conditionally activated biologics that increase drug efficiency and reduce side effects. Strategic partnerships with leading companies like Amgen, Astell...
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a firesid...
Message Board Posts | CytomX Therapeutics Inc. (NASDAQ:CTMX)
Subject | By | Source | When |
---|---|---|---|
Price gaining up | alstocks | investorshub | 06/28/2023 3:51:30 PM |
$CTMX and the shorts continue | alstocks | investorshub | 06/28/2023 8:32:04 AM |
Price trading up | TheFinalCD | investorshub | 06/24/2023 9:54:22 AM |
$CTMX MomentumIts now | Triple nickle | investorshub | 06/23/2023 4:28:00 AM |
MomentumIts gaining up | alexjames81 | investorshub | 06/20/2023 8:24:35 PM |
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
CytomX Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a firesid...
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024. “Chris has mad...